Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Inhibiting AP1 in mice skin causes structural changes and weakens the skin barrier.

Hair thinning is a common but generally mild and reversible side effect of teriflunomide in multiple sclerosis patients.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

Blood vessel patterns in skin diseases relate to certain blood markers in systemic sclerosis but not in psoriasis or psoriatic arthritis, and may indicate circulation issues in alopecia.

Unique fat cells near fibrotic areas contribute to systemic sclerosis progression.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Chaga mushrooms contain compounds that may promote hair growth better than common treatments.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Cladribine has known risks and potential new safety concerns, requiring careful monitoring.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Topical treatments led to hair regrowth in a man with linear morphea.

Cells from a skin condition can create new hair follicles and similar growths in mice, and a specific treatment can reduce these effects.

Rapid weight loss from dieting and hormonal injections can cause significant hair loss in women.

Skin problems in the elderly are unique and may indicate other diseases, involving changes in skin, hair, nails, and increased cancer risk.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Minoxidil may cause heart issues in animals and humans.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

High doses of tryptophan may cause eosinophilic fasciitis.

A family showed a new condition with inherited hair loss and skin changes, possibly due to one genetic disorder.

Some skin problems can be signs of diabetes or other metabolic diseases and recognizing them can help diagnose and treat these diseases early.

Tissue expansion is an effective treatment for certain types of hair loss, providing immediate coverage with hair-bearing skin.

Ectodin integrates BMP, SHH, and FGF signals in developing ectodermal organs.

Pregnancy can cause various skin changes and diseases, with PUPPP being the most common skin condition specific to pregnancy.